NCT06193902View on ClinicalTrials.gov

LEU01101: Safety and Preliminary Efficacy of LEU011 in Solid Tumours.

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

17

Participants

Timeline

Start Date

November 13, 2023

Primary Completion Date

May 31, 2029

Study Completion Date

May 31, 2029

Conditions

Tumor, Solid

Interventions

BIOLOGICAL

LEU011

Immunotherapy

Trial Locations (2)

SE1 9RT

RECRUITING

Guy's and St Thomas' NHS Foundation Trust, London

M20 4BX

RECRUITING

The Christie NHS Foundation Trust, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Leucid Bio

INDUSTRY